N-methyl-N-(2-pyridinylmethyl)glycine dihydrochloride hydrate, 95.0%, 10g

1-Methyl-6-oxo-1,6-dihydropyridine-3-carbonitrile, 97%, 5g

(2S,4S)-4-AMINOPYRROLIDINE-2-CARBOXYLIC ACID DIHYDROCHLORIDE, 95.0%, 1g

2-(tert-Butyl)-6-(5-chloro-2H-benzo[d][1,2,3]triazol-2-yl)-4-methylphenol, 95.0%, 1kg

1-Bromo-5-fluoro-4-iodo-2-nitrobenzene, 95.0%, 25g

3-Bromopicolinamide, 97%, 25g

Methyl 4-iodobenzo[b]thiophene-2-carboxylate, 95.0%, 1g

4-(Aminomethyl)-1-benzylpiperidin-4-ol, 95.0%, 1g

1,2-dimetoxietano, mínimo 99 %, para síntesis, 500 ml, envase de vidrio

1-(1,4-Diazepan-1-yl)ethanone, 97.0%, 1g

4-bromo-2,5-dimethyl-1H-imidazole, 95.0%, 5g

(2E)-1-(3-bromophenyl)-3-(2-methoxyphenyl)prop-2-en-1-one, 95.0%, 10g

Sodium 3-chloro-2-hydroxypropane-1-sulfonate, 95.0%, 500g